Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model.

Belloni L, Di Cocco S, Guerrieri F, Nunn ADG, Piconese S, Salerno D, Testoni B, Pulito C, Mori F, Pallocca M, Sacconi A, Vivoli E, Marra F, Strano S, Blandino G, Levrero M, Pediconi N.

Sci Rep. 2018 Sep 11;8(1):13638. doi: 10.1038/s41598-018-31835-2.

2.

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.

Spagnuolo M, Regazzo G, De Dominici M, Sacconi A, Pelosi A, Korita E, Marchesi F, Pisani F, Magenta A, Lulli V, Cordone I, Mengarelli A, Strano S, Blandino G, Rizzo MG, Calabretta B.

Haematologica. 2019 Jan;104(1):82-92. doi: 10.3324/haematol.2018.191213. Epub 2018 Aug 3.

3.

Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.

Ferraiuolo M, Pulito C, Finch-Edmondson M, Korita E, Maidecchi A, Donzelli S, Muti P, Serra M, Sudol M, Strano S, Blandino G.

Cancer Lett. 2018 Oct 1;433:18-32. doi: 10.1016/j.canlet.2018.06.021. Epub 2018 Jun 19.

4.

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.

Lo Sardo F, Strano S, Blandino G.

Cancers (Basel). 2018 May 6;10(5). pii: E137. doi: 10.3390/cancers10050137. Review.

5.

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.

Di Agostino S, Valenti F, Sacconi A, Fontemaggi G, Pallocca M, Pulito C, Ganci F, Muti P, Strano S, Blandino G.

Theranostics. 2018 Feb 12;8(7):1850-1868. doi: 10.7150/thno.22167. eCollection 2018.

6.

HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.

di Martino S, Amoreo CA, Nuvoli B, Galati R, Strano S, Facciolo F, Alessandrini G, Pass HI, Ciliberto G, Blandino G, De Maria R, Cioce M.

Oncogene. 2018 Mar;37(10):1369-1385. doi: 10.1038/s41388-017-0044-8. Epub 2018 Jan 9.

PMID:
29311642
7.

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex.

Verduci L, Ferraiuolo M, Sacconi A, Ganci F, Vitale J, Colombo T, Paci P, Strano S, Macino G, Rajewsky N, Blandino G.

Genome Biol. 2017 Dec 20;18(1):237. doi: 10.1186/s13059-017-1368-y.

8.

MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.

Frixa T, Sacconi A, Cioce M, Roscilli G, Ferrara FF, Aurisicchio L, Pulito C, Telera S, Carosi M, Muti P, Strano S, Donzelli S, Blandino G.

Carcinogenesis. 2018 Feb 9;39(2):293-304. doi: 10.1093/carcin/bgx134.

PMID:
29236960
9.

MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective study.

Muti P, Donzelli S, Sacconi A, Hossain A, Ganci F, Frixa T, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G.

Carcinogenesis. 2018 Feb 9;39(2):98-108. doi: 10.1093/carcin/bgx126.

PMID:
29126102
10.

Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.

Cusumano G, Fournel L, Strano S, Damotte D, Charpentier MC, Galia A, Terminella A, Nicolosi M, Regnard JF, Alifano M.

Lung. 2017 Dec;195(6):789-798. doi: 10.1007/s00408-017-0056-8. Epub 2017 Oct 11.

PMID:
29022070
11.

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

Lo Sardo F, Muti P, Blandino G, Strano S.

Int J Mol Sci. 2017 Sep 6;18(9). pii: E1913. doi: 10.3390/ijms18091913.

12.

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Ganci F, Sacconi A, Manciocco V, Covello R, Benevolo M, Rollo F, Strano S, Valsoni S, Bicciato S, Spriano G, Muti P, Fontemaggi G, Blandino G.

Mod Pathol. 2017 Oct;30(10):1387-1401. doi: 10.1038/modpathol.2017.62. Epub 2017 Jul 21.

13.

MicroRNAs as Key Effectors in the p53 Network.

Goeman F, Strano S, Blandino G.

Int Rev Cell Mol Biol. 2017;333:51-90. doi: 10.1016/bs.ircmb.2017.04.003. Epub 2017 May 22. Review.

PMID:
28729028
14.

Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, Campagnoli C, Berrino F, Fanciulli M, Ford RJ, Levrero M, Pediconi N, Ciuffreda L, Milella M, Steinberg GR, Cioce M, Muti P, Strano S, Blandino G.

Cell Discov. 2017 Jul 4;3:17022. doi: 10.1038/celldisc.2017.22. eCollection 2017.

15.

Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer.

Banna GL, Parra HJS, Castaing M, Dieci MV, Anile G, Nicolosi M, Strano S, Marletta F, Guarneri V, Conte P, Lal R.

Anticancer Res. 2017 Jul;37(7):3723-3728.

PMID:
28668866
16.

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.

Ferraiuolo M, Verduci L, Blandino G, Strano S.

Int J Mol Sci. 2017 May 3;18(5). pii: E961. doi: 10.3390/ijms18050961. Review.

17.

Orthostatic Intolerance and Postural Orthostatic Tachycardia Syndrome in Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome, Hypermobility Type: Neurovegetative Dysregulation or Autonomic Failure?

Celletti C, Camerota F, Castori M, Censi F, Gioffrè L, Calcagnini G, Strano S.

Biomed Res Int. 2017;2017:9161865. doi: 10.1155/2017/9161865. Epub 2017 Feb 12.

18.

MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.

Canu V, Sacconi A, Lorenzon L, Biagioni F, Lo Sardo F, Diodoro MG, Muti P, Garofalo A, Strano S, D'Errico A, Grazi GL, Cioce M, Blandino G.

Oncotarget. 2017 May 2;8(18):29540-29557. doi: 10.18632/oncotarget.15290.

19.

Cutis tricolor: a literature review and report of five new cases.

Ruggieri M, Polizzi A, Schepis C, Morano M, Strano S, Belfiore G, Palmucci S, Foti PV, Pirrone C, Roggini M, David E, Salpietro V, Milone P.

Quant Imaging Med Surg. 2016 Oct;6(5):525-534.

20.

Mixed vascular nevus syndrome: a report of four new cases and a literature review.

Ruggieri M, Polizzi A, Strano S, Schepis C, Morano M, Belfiore G, Palmucci S, Foti PV, Pirrone C, Sofia V, David E, Salpietro V, Mankad K, Milone P.

Quant Imaging Med Surg. 2016 Oct;6(5):515-524.

21.

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.

Lieberman S, Tomer A, Ben-Chetrit A, Olsha O, Strano S, Beeri R, Koka S, Fridman H, Djemal K, Glick I, Zalut T, Segev S, Sklair M, Kaufman B, Lahad A, Raz A, Levy-Lahad E.

Genet Med. 2017 Jul;19(7):754-762. doi: 10.1038/gim.2016.182. Epub 2016 Dec 8.

PMID:
27929526
22.

Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer.

Banna GL, Anile G, Russo G, Vigneri P, Castaing M, Nicolosi M, Strano S, Gieri S, Spina R, Patanè D, Calcara G, Fraggetta F, Marletta F, Stefano A, Ippolito M.

Oncology. 2017;92(1):39-47. doi: 10.1159/000448005. Epub 2016 Nov 11.

PMID:
27832654
23.

MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.

Lo Sardo F, Forcato M, Sacconi A, Capaci V, Zanconato F, Di Agostino S, Del Sal G, Pandolfi PP, Strano S, Bicciato S, Blandino G.

Carcinogenesis. 2017 Jan;38(1):64-75. doi: 10.1093/carcin/bgw110. Epub 2016 Oct 17.

24.

Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment.

Strano S, Fanciulli A, Rizzo M, Marinelli P, Palange P, Tiple D, De Vincentis G, Calcagnini G, Censi F, Meco G, Colosimo C.

J Neurol Sci. 2016 Nov 15;370:251-255. doi: 10.1016/j.jns.2016.09.036. Epub 2016 Sep 21.

PMID:
27772769
25.

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or ...both?

Cioce M, Strano S, Muti P, Blandino G.

Aging (Albany NY). 2016 May;8(5):1153-5. doi: 10.18632/aging.100965. No abstract available.

26.

Oncogenic Intra-p53 Family Member Interactions in Human Cancers.

Ferraiuolo M, Di Agostino S, Blandino G, Strano S.

Front Oncol. 2016 Mar 31;6:77. doi: 10.3389/fonc.2016.00077. eCollection 2016. Review.

27.

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Mori F, Ferraiuolo M, Santoro R, Sacconi A, Goeman F, Pallocca M, Pulito C, Korita E, Fanciulli M, Muti P, Blandino G, Strano S.

Oncotarget. 2016 Apr 12;7(15):20532-48. doi: 10.18632/oncotarget.7978.

28.

Preface.

Strano S.

Methods Mol Biol. 2016;1379:v. No abstract available.

PMID:
26937500
29.
30.

Sibling cord blood donor program for hematopoietic cell transplantation: the 20-year experience in the Rome Cord Blood Bank.

Screnci M, Murgi E, Valle V, Tamburini A, Pellegrini MG, Strano S, Corona F, Ambrogi EB, Girelli G.

Blood Cells Mol Dis. 2016 Mar;57:71-3. doi: 10.1016/j.bcmd.2015.12.010. Epub 2016 Jan 3.

PMID:
26852659
31.

Supine hypertension in Parkinson's disease and multiple system atrophy.

Fanciulli A, Göbel G, Ndayisaba JP, Granata R, Duerr S, Strano S, Colosimo C, Poewe W, Pontieri FE, Wenning GK.

Clin Auton Res. 2016 Apr;26(2):97-105. doi: 10.1007/s10286-015-0336-4. Epub 2016 Jan 22.

PMID:
26801189
32.

MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.

Donzelli S, Cioce M, Muti P, Strano S, Yarden Y, Blandino G.

Semin Cell Dev Biol. 2016 Feb;50:133-42. doi: 10.1016/j.semcdb.2015.12.020. Epub 2016 Jan 7. Review.

PMID:
26773212
33.

YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.

Di Agostino S, Sorrentino G, Ingallina E, Valenti F, Ferraiuolo M, Bicciato S, Piazza S, Strano S, Del Sal G, Blandino G.

EMBO Rep. 2016 Feb;17(2):188-201. doi: 10.15252/embr.201540488. Epub 2015 Dec 21.

34.

Antibody Array as a Tool for Screening of Natural Agents in Cancer Chemoprevention.

Pulito C, Sacconi A, Korita E, Maidecchi A, Strano S.

Methods Mol Biol. 2016;1379:189-99. doi: 10.1007/978-1-4939-3191-0_17.

PMID:
26608301
35.

Cancer Gastric Chemoprevention: Isolation of Gastric Tumor-Initiating Cells.

Mori F, Canu V, Lorenzon L, Garofalo A, Blandino G, Strano S.

Methods Mol Biol. 2016;1379:129-37. doi: 10.1007/978-1-4939-3191-0_12.

PMID:
26608296
36.

Comet Assay in Cancer Chemoprevention.

Santoro R, Ferraiuolo M, Morgano GP, Muti P, Strano S.

Methods Mol Biol. 2016;1379:99-105. doi: 10.1007/978-1-4939-3191-0_9.

PMID:
26608293
37.

Epigenetic silencing of miR-145-5p contributes to brain metastasis.

Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, Carosi MA, Pescarmona E, Segatto O, Pond G, Muti P, Telera S, Strano S, Yarden Y, Blandino G.

Oncotarget. 2015 Nov 3;6(34):35183-201. doi: 10.18632/oncotarget.5930.

38.

What biomarkers (if any) for precise medicine?

Strano S, Muti P, Blandino G.

Aging (Albany NY). 2015 Aug;7(8):533-4. No abstract available.

39.

Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion.

Pulito C, Mori F, Sacconi A, Casadei L, Ferraiuolo M, Valerio MC, Santoro R, Goeman F, Maidecchi A, Mattoli L, Manetti C, Di Agostino S, Muti P, Blandino G, Strano S.

Oncotarget. 2015 Jul 20;6(20):18134-50.

40.

miR-181c associates with tumor relapse of high grade osteosarcoma.

Mori F, Sacconi A, Canu V, Ganci F, Novello M, Anelli V, Covello R, Ferraresi V, Muti P, Biagini R, Blandino G, Strano S.

Oncotarget. 2015 Jun 10;6(16):13946-61.

41.

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E.

PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015.

42.

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.

Valenti F, Ganci F, Fontemaggi G, Sacconi A, Strano S, Blandino G, Di Agostino S.

Oncotarget. 2015 Mar 20;6(8):5547-66.

43.

microRNAs: short non-coding bullets of gain of function mutant p53 proteins.

Donzelli S, Strano S, Blandino G.

Oncoscience. 2014 Jun 7;1(6):427-33. eCollection 2014.

44.

MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.

Ganci F, Sacconi A, Manciocco V, Sperduti I, Battaglia P, Covello R, Muti P, Strano S, Spriano G, Fontemaggi G, Blandino G.

Head Neck. 2016 Apr;38 Suppl 1:E189-97. doi: 10.1002/hed.23969. Epub 2015 Jun 24.

PMID:
25532855
45.

microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Pulito C, Donzelli S, Muti P, Puzzo L, Strano S, Blandino G.

Ann Transl Med. 2014 Jun;2(6):58. doi: 10.3978/j.issn.2305-5839.2014.06.03. Review.

46.

Transcriptional regulation by mutant p53 and oncogenesis.

Santoro R, Strano S, Blandino G.

Subcell Biochem. 2014;85:91-103. doi: 10.1007/978-94-017-9211-0_5. Review.

PMID:
25201190
47.

Is patent foramen ovale closure an OPTION in patients with cryptogenic stroke? An Italian multicentre registry proposal.

Faggiano P, Toni D, Strano S, Seccareccia F.

J Cardiovasc Med (Hagerstown). 2014 Oct;15(10):769-70. doi: 10.2459/JCM.0000000000000182. No abstract available.

PMID:
25162175
48.

Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study.

Muti P, Sacconi A, Hossain A, Donzelli S, Ben Moshe NB, Ganci F, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2471-81. doi: 10.1158/1055-9965.EPI-14-0398. Epub 2014 Jul 29.

49.

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.

Cioce M, Valerio M, Casadei L, Pulito C, Sacconi A, Mori F, Biagioni F, Manetti C, Muti P, Strano S, Blandino G.

Oncotarget. 2014 Jun 30;5(12):4129-43.

50.

Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal.

Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, Russo C.

Int J Environ Res Public Health. 2014 May 8;11(5):4965-77. doi: 10.3390/ijerph110504965.

Supplemental Content

Loading ...
Support Center